What are the clinical criteria for differentiating between benign and malignant skin lesions, and what factors increase the risk of developing malignant skin lesions such as malignant melanoma? What is the Glasgow 7-point checklist, and how is histological analysis used to predict prognosis and survival rates? Additionally, how can both medical personnel and the government play a role in managing and preventing malignant melanoma? Finally, what are the symptoms and diagnosis of bladder cancer, and how can early detection and family support impact prognosis and treatment?